Ryan C. Lynch, MD
Before I started medical school, I had the opportunity to work in a research lab that studied the development of blood vessels in tumors. Many of the lab’s ongoing projects were being translated into novel therapeutics. Becoming an oncologist was a way I could help bring those therapies to patients. As my training progressed, I worked in oncology clinics and witnessed the translation from bench to bedside firsthand. That experience inspired me to work directly with patients while also exploring novel treatments for lymphomas and chronic lymphocytic leukemia through clinical trials.
Every person handles their cancer diagnosis differently; it can set off a wide range of feelings and life changes that are unique to each individual. I enjoy connecting with patients and families, learning about your goals for care, your hopes, your plans for the future and your concerns. It is my job to help you understand and feel comfortable with your treatment plan, whether you’re receiving a standard therapy, choosing a novel approach or participating in a clinical trial.
Specialty: Medical Oncology
I am a board-certified hematologist-oncologist who specializes in caring for patients with lymphomas and chronic lymphocytic leukemia (CLL). I am also involved in clinical research for these diseases. While many excellent therapies are available for CLL and lymphomas, they don’t work for every patient. I conduct clinical trials to optimize treatments and bring novel therapeutic agents to the clinic.
About two weeks before Harvey turned 73, he discovered a lump over his left collarbone. “It just showed up when I looked in the mirror,” he says. He went to get it checked out by his doctor, and although a sonogram did show the lump, a needle biopsy didn’t reveal anything unusual. That didn’t seem right, so his doctor sent Harvey in for a computer tomography (CT) scan, which would be better able to scan the lump.
Learn about the latest innovations in hematologic oncology.
We make promising new treatments available to you through studies called clinical trials led by Fred Hutch doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our Fred Hutch doctors conduct ongoing research to improve standards of patient care. Their work is evaluated by other doctors and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch provider has written.
Our providers are often asked to give their medical expertise for press and news publications. Read articles by or about this Fred Hutch provider.
Key research spans CAR T-cell therapies and treatments for myeloma, leukemia and more.
SCCA’s Dr. Ryan Lynch was quoted in a Reuters Health story about results of the first prospective clinical trial of combination immunotherapy in angiosarcoma.
Your care team
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.